Do antipsychotic drugs block insulin action in the brain?
Official title: Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?
Run by Centre for Addiction and Mental Health · NCT07109245 · Data updated 2026-11-12
This project will test whether haloperidol blocks insulin action in the brain of healthy adults aged 18–35.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 35 (estimated) |
| Sponsor | Centre for Addiction and Mental Health Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | December 11, 2025 |
| Main results expected | August 2028 |
| Study ends | December 2028 |
| Registry record updated | April 2, 2026 |
| Trial ID | NCT07109245 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 18–35 with BMI 18.5–24.9, normal glucose metabolism and insulin sensitivity, no psychiatric history, and ability to consent are ideal candidates.
✕Probably not a fit
People with psychiatric disorders, diabetes or prediabetes, impaired insulin sensitivity, a family history of diabetes, or outside the specified age/BMI ranges are not eligible and are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 4 interventional study enrolls healthy 18–35-year-old adults with normal BMI and no psychiatric or metabolic disorders. Participants receive pharmacologic challenges with haloperidol or placebo and with insulin lispro or saline while investigators measure brain responses and cognition using MRI and cognitive tests. The design compares brain insulin signaling and cognitive effects after antipsychotic versus placebo exposure to see if haloperidol interferes with insulin action in the brain. Strict metabolic and psychiatric exclusion criteria are used to isolate drug effects in metabolically healthy volunteers.
Why it matters
Potential benefit: If successful, the results could clarify whether antipsychotics impair brain insulin signaling and inform strategies to reduce metabolic and cognitive side effects in patients on these drugs.
How similar studies have gone: Prior research has linked antipsychotics to systemic metabolic side effects and altered cognition, but direct effects of haloperidol on brain insulin signaling remain relatively novel and not well-established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Must be deemed to have the capacity to provide informed consent 2. Must sign and date the informed consent form 3. Stated willingness to comply with all study procedures; 4. Age: 18-35 5. Body Mass Index (BMI) 18.5-24.9 kg/m2 6. Both sexes Exclusion Criteria: 1. History of psychiatric illness, including any substance use (screened using the Mini International Neuropsychiatric Interview (MINI)) 2. Pre-diabetes or diabetes (fasting glucose ≥6.0 mmol/L, HbA1c\>6% or use of anti-diabetic drug), 3. Evidence of impaired insulin sensitivity, assessed using the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) ≥2.5 4. Family history of diabetes in a first degree relative (parent or sibling) 5. Use of weight reducing agents 6. History of kidney or liver disease 7. History of cell blood disorders 8. Irregular menstrual cycles (e.g., menstruation occurs less than 21 days or more than 35 days apart, or not having menstruated for three months (or 90 days), or conditions such as endometriosis or polycystic ovary syndrome (PCOS) or prior surgical interventions such as a hysterectomy or oophorectomy) 9. Current use of hormonal birth control (e.g., pill, patch, hormonal intrauterine device \[IUD\], ring). Participants must have had at least 2 regular menstrual cycles following the discontinuation of hormonal birth control \[50\] 10. Current use of progesterone, estrogen, testosterone, or fertility treatment. 11. Pregnant, gave birth in the last year, or breastfeeding. Participants must have at least 3 regular menstrual cycles post-breastfeeding before beginning the study. 12. Major medical or surgical event within the last 6 months 13. Contraindications for MRI, including metal implants, pacemakers, cochlear implants, claustrophobia, weight \>250 lbs 14. Any contraindications to the investigational products as listed in the product monographs including known hypersensitivity to the drug or the excipients of the product (note: enzymatic lactose intolerance is NOT exclusionary), 15. Any medications that increases risk of hypoglycemia or could contribute to hyperglycemia 16. Any medical conditions that constitute as a warning/precaution for haloperidol, lorazepam, benztropine, or insulin. 17. Use of any of the prohibited medications listed in the product monograph of haloperidol, lorazepam, benztropine, or insulin (Pheochromocytoma, barbiturates, and narcotics are exclusionary, any use of painkillers and antihistamines must be reviewed by PI but are not exclusionary
Where it's running
-
Centre for Addiction and Mental Health
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Mahavir Agarwal, MBBS, MD, PhD — Centre for Addiction and Mental Health
- Study coordinator: Mahavir Agarwal, MBBS, MD, PhD
- Email: mahavir.agarwal@camh.ca
- Phone: 416-535-8501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can the Ronnie Gardiner Method improve thinking and daily function in people with Parkinson’s
In this 10-week program, adults with Parkinson’s disease will try the Ronnie Gardiner Method to see if it helps thinking, talking, movement, balance, and quality of life.
-
Beef-Protein Ready-to-Eat Meals to Support Firefighter Recovery
This study tests whether beef-based ready-to-eat meals help firefighters recover better after simulated firefighting tasks, compared with plant-based meals.
-
How pork protein affects recovery after simulated firefighting
This study tests whether pork-based meals help firefighters recover better and perform sooner after hard simulated fire drills, compared with plant-based meals or carbohydrate-focused meals.
-
LpD3.5 Intervention for Gut Health and Cognition in Older Adults with MCI
In older adults with mild cognitive impairment, this study tests whether daily LpD3.5 capsules can improve gut health and potentially cognition compared with placebo.
-
Ketone and Carbohydrate Supplementation in Endurance Cycling
This study tests whether adding ketones to a carb plan helps amateur endurance cyclists perform better and think more clearly during long, exhausting rides.
-
Appetite and Thinking Response to a Breakfast Cereal
This study tests how eating a ready-to-eat breakfast cereal affects appetite and thinking in healthy adults who regularly eat cereal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.